AsymBio
AsymBio, a subsidiary of Asymchem Group, is a technology‑driven global CDMO specializing in biologics, including bioconjugates (ADCs, BsADCs, dpADCs, AOCs, APCs, ARCs, DACs), antibodies and recombinant proteins. With 1,000+ professionals in Tianjin and Shanghai, we provide end-to-end solutions from early-stage research and process development through toxicology and clinical batches to commercial manufacturing. Supported by large-scale GMP facilities and an international quality system aligned with US, EU and China requirements, we deliver innovative, reliable, client-focused solutions.
